Methods and reagents that generate a CD8 T cell immune response
US7407661B2 · kind B2 · utility
2Cited by
11References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2004 |
| Grant date | Aug 5, 2008 |
| Priority date | — |
| Expiry date | Oct 20, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
New methods and reagents for vaccination are described which generate a CD8 T cell immune response against malarial and other antigens such as viral and tumour antigens. Novel vaccination regimes are described which employ a priming composition and a boosting composition, the boosting composition comprising a non-replicating or replication-impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.